| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Articles |
Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York 12208
Abstract
The 44-amino acid bovine papillomavirus E5 protein induces tumorigenic transformation of immortal rodent fibroblasts by binding to and activating the platelet-derived growth factor ß receptor (PDGFßR). Here E5 was expressed in mortal human diploid fibroblasts (HDFs), which lack the accumulated genetic changes that are present in immortal rodent cells. E5 induced focus formation and morphological transformation of HDFs without inducing anchorage independence or immortalization. Similar effects were observed with the v-sis and neu* oncogenes. E5-PDGFßR complexes were observed in the E5-expressing HDFs, as was constitutive PDGFßR activation, which was required for the transforming activity of E5. The E5 HDFs attained a higher saturation density than the control cells, expressing increased levels of hyperphosphorylated retinoblastoma protein at subconfluent densities. However, when these cells reached confluence, growth inhibition accompanied by dramatic down-regulation of the PDGFßR, and retinoblastoma protein was induced apparently by a factor secreted into the medium. This may represent a novel negative feedback mechanism controlling PDGFßR-induced proliferation and thereby protecting against complete transformation.
This article has been cited by other articles:
![]() |
L. M. Petti, E. C. Ricciardi, H. J. Page, and K. A. Porter Transforming signals resulting from sustained activation of the PDGF{beta} receptor in mortal human fibroblasts J. Cell Sci., April 15, 2008; 121(8): 1172 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Narechania, M. Terai, Z. Chen, R. DeSalle, and R. D. Burk Lack of the canonical pRB-binding domain in the E7 ORF of artiodactyl papillomaviruses is associated with the development of fibropapillomas J. Gen. Virol., May 1, 2004; 85(5): 1243 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. M. Lehman, and L. M. Petti Apoptosis of Mortal Human Fibroblasts Transformed by the Bovine Papillomavirus E5 Oncoprotein Mol. Cancer Res., December 1, 2002; 1(2): 122 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Nappi, J. A. Schaefer, and L. M. Petti Molecular Examination of the Transmembrane Requirements of the Platelet-derived Growth Factor beta Receptor for a Productive Interaction with the Bovine Papillomavirus E5 Oncoprotein J. Biol. Chem., November 27, 2002; 277(49): 47149 - 47159. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Nappi and L. M. Petti Multiple Transmembrane Amino Acid Requirements Suggest a Highly Specific Interaction between the Bovine Papillomavirus E5 Oncoprotein and the Platelet-Derived Growth Factor Beta Receptor J. Virol., August 15, 2002; 76(16): 7976 - 7986. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Penington, I. Bryant, and D. J. Riese II Constitutively Active ErbB4 and ErbB2 Mutants Exhibit Distinct Biological Activities Cell Growth Differ., June 1, 2002; 13(6): 247 - 256. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |